Immunology

Items 211-220 of 371

per page
Set Descending Direction
  1. EGFR, Soluble (human) (rec.)
    AG-40T-0041
    AG-40T-0041-C02525 µg
    CHF 620.00
  2. Erythroferrone (human) ELISA Kit
    AG-45B-0014
    AG-45B-0014-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  3. Erythroferrone (human) Matched Pair Detection Set
    AG-46B-0012
    AG-46B-0012-KI011 Set
    CHF 750.00
    Erythroferrone (human) Matched Pair Detection Set
  4. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  5. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  6. Fc (human) IgG1 Control (rec.)
    AG-35B-0007
    AG-35B-0007-C05050 µg
    CHF 170.00
    AG-35B-0007-20502 x 50 µg
    CHF 290.00
    AG-35B-0007-C500500 µg
    CHF 720.00
    AG-35B-0007-M0011 mg
    CHF 1'270.00
  7. Fc (human) IgG1 Control (rec.) (non-lytic)
    AG-35B-0016
    AG-35B-0016-C01010 µg
    CHF 340.00
    AG-35B-0016-30103 x 10 µg
    CHF 680.00
    AG-35B-0016-C100100 µg
    CHF 1'360.00
  8. Fc (human) IgG2 Control (rec.)
    AG-35B-0009
    AG-35B-0009-C05050 µg
    CHF 200.00
    AG-35B-0009-20502 x 50 µg
    CHF 350.00
  9. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper
  10. Fc (human):CD137L, Soluble (human) (rec.)
    AG-40B-0173
    AG-40B-0173-C01010 µg
    CHF 265.00
    AG-40B-0173-30103 x 10 µg
    CHF 530.00
    Fc (human):CD137L, Soluble (human) (rec.) (AG-40B-0173) binds to human CD137. Method: CD137 (human):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations of Fc (human):CD137L, Soluble (human) (AG-40B-

Items 211-220 of 371

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.